Back to products

Semaglutide

10mg

10mg · Research grade

PRIMELABSSEMAGLUTIDE5mlprimelabs.com
$79per vial
1

Buy 2+ vials to unlock bundle savings (5% / 10% / 15%). Add more to reach $150 for free shipping.

Overview

Semaglutide is a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist widely studied for its role in metabolic and endocrine research. Its extended duration of action has made it a valuable compound for investigating metabolic physiology.

Mechanism

Semaglutide acts as a GLP-1 receptor agonist with albumin-binding modification extending half-life. Research examines GLP-1 receptor-mediated effects on glucose homeostasis, gastric motility, and metabolic signaling.

Areas of Active Scientific Research

Research continues to evaluate its effects on glucose regulation, appetite signaling, gastric emptying, energy balance, and overall metabolic function, contributing to a deeper understanding of GLP-1 receptor biology.

Molecular Characteristics

Molecular weight
4113.6 Da
Formula
C187H291N45O59
Sequence
31 amino acid GLP-1 analog with C18 fatty di-acid side chain
Appearance
White lyophilized powder in sealed research vial.
Dose
10mg
Grade
Research grade (RUO)

Storage Recommendations

For laboratory research use only. Store lyophilized material at −20°C or below. Reconstitute and handle according to institutional SOPs for peptide research.

Purity

Target purity ≥99% by HPLC for this research-grade batch. See the Certificate of Analysis for batch-specific analytical results.

≥99.0%

Batch Number

Current batch identifier for traceability and COA lookup:

PL-SEM-10-26042

Date Tested: 2026-04-18

Certificate of Analysis

Semaglutide 10mg · Third-party verified batch documentation

Download PDF
Laboratory Name
Independent Analytical Laboratory (ISO/IEC 17025)
Purity %
≥99.0%
Batch Number
PL-SEM-10-26042
Date Tested
2026-04-18

What a COA demonstrates

Batch-specific identity verification, purity by validated analytical methods (e.g. HPLC), and third-party laboratory testing records for the referenced lot.

What a COA does not demonstrate

Clinical efficacy, safety for human or veterinary use, or suitability for any application outside qualified laboratory research.

Quality Assurance

Every Prime Labs peptide undergoes rigorous quality control procedures and is accompanied by batch specific analytical documentation to support identity and purity verification.

References

Selected peer-reviewed literature for research context. Prime Labs citations do not constitute therapeutic claims.

  1. Wilding J.P.H. et al. — Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine, 2021.

Frequently Asked Questions · Semaglutide